| 摘要 |
<p>The invention relates to a method for the manufacture of a pharmaceutical form of oseltamivir phosphate, characterized in that it comprises the following steps: a) compacting followed by screening of an oseltamivir phosphate powder; b) dry-mixing, with known excipients, of the product obtained at the end of the previous step, followed by screening. Application to an industrial production suitable for a crisis situation, such as a pandemic.</p> |
